Skip to main content

Find Clinical Trials

Home
Conditions
Fatty Liver

Clinical trial condition

Fatty Liver

Explore clinical trials studying Fatty Liver. Study availability and eligibility vary by location and protocol.

953 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Fatty Liver trial results

Not Yet Recruiting

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

NCT04925362

Conditions: Cirrhosis, Digestive System Diseases, Fatty Liver, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese

NCT03282305

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH

NCT06297434

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Dong-A University Hospital Busan, South Korea

Hallym University Dongtan Sacred Heart Hospital Gyeonggi-do, South Korea

Hallym University Sacred Heart Hospital Gyeonggi-do, South Korea

Gyeongsang National University Hospital Gyeongsang, South Korea

View Trial Details

Completed

Analysis of Renal Impairment Characteristics and High-Risk Factors in Chronic Hepatitis B Patients on Long-Term Oral Nucleos(t)Ide Analogues

NCT07730905

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: Foshan Hospital of Traditional Chinese Medicine Foshan, Guangdong, China

View Trial Details

Completed

Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents

NCT05268042

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients

NCT04785937

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +8 more
Locations: Azienda USL-IRCCS di Reggio Emilia Reggio Emilia, RE, Italy

View Trial Details

Completed

A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

NCT05039450

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Akero Clinical Study Site Chandler, Arizona, United States

Akero Clinical Study Site Glendale, Arizona, United States

Akero Clinical Study Site Tucson, Arizona, United States

Akero Clinical Study Site Tucson, Arizona, United States

View all 49 locations

View Trial Details

Completed

Iron Depletion Therapy for Type 2 DM and NAFLD

NCT00230087

Conditions: Diabetes Mellitus, Digestive System Diseases, Endocrine System Diseases, +7 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Effect of Omega-3 PUFA Supplementation in NAFLD Patients

NCT00230113

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

NCT04880031

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Central Research Associates Birmingham, Alabama, United States

Arizona Liver Health Chandler, Arizona, United States

Arizona Liver Health Peoria, Arizona, United States

Arizona Liver Health Tucson, Arizona, United States

View all 48 locations

View Trial Details